Results 231 to 240 of about 4,326,867 (382)
Shaping the Future of HTA in Italy: Insights from the Italian Health Policy Forum. [PDF]
J Mark Access Health PolicySciattella P +5 more
europepmc +1 more source
The economics of status, institutional design and economic policy [PDF]
, 2015 Теодор Седларски
openalex +1 more source
British Journal of Clinical Pharmacology, EarlyView.Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Research on the U-shaped relationship between marketization process and corporate capital structure: Evidence from Chinese listed companies. [PDF]
PLoS OneXu J, Zhang L.
europepmc +1 more source
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
British Journal of Clinical Pharmacology, EarlyView.Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source
Extension agents' attitudes and participation in disseminating climate-smart agricultural practices in North-Central, Nigeria. [PDF]
Front NutrOjo IE +8 more
europepmc +1 more source